0.7964
price down icon4.95%   -0.0415
 
loading
Shattuck Labs Inc stock is traded at $0.7964, with a volume of 109.36K. It is down -4.95% in the last 24 hours and down -33.08% over the past month. Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$0.8379
Open:
$0.8356
24h Volume:
109.36K
Relative Volume:
0.54
Market Cap:
$37.61M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-0.4126
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
+2.99%
1M Performance:
-33.08%
6M Performance:
-39.21%
1Y Performance:
-91.86%
1-Day Range:
Value
$0.7801
$0.8715
1-Week Range:
Value
$0.76
$0.90
52-Week Range:
Value
$0.6922
$11.76

Shattuck Labs Inc Stock (STTK) Company Profile

Name
Name
Shattuck Labs Inc
Name
Phone
512-900-4690
Name
Address
500 W. 5TH STREET, AUSTIN
Name
Employee
44
Name
Twitter
Name
Next Earnings Date
2025-03-26
Name
Latest SEC Filings
Name
STTK's Discussions on Twitter

Compare STTK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
STTK
Shattuck Labs Inc
0.7964 37.61M 2.72M -85.08M -70.93M -1.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-17-25 Initiated Leerink Partners Outperform
Oct-02-24 Downgrade Citigroup Buy → Neutral
Oct-02-24 Downgrade Needham Buy → Hold
Oct-01-24 Downgrade H.C. Wainwright Buy → Neutral
Jun-17-24 Downgrade BTIG Research Buy → Neutral
Aug-31-22 Initiated BTIG Research Buy
Jun-01-22 Initiated Citigroup Buy
May-02-22 Initiated H.C. Wainwright Buy
Apr-14-21 Initiated Berenberg Buy
Jan-11-21 Initiated Evercore ISI Outperform
Nov-03-20 Initiated Citigroup Buy
Nov-03-20 Initiated Cowen Outperform
Nov-03-20 Initiated Needham Buy
View All

Shattuck Labs Inc Stock (STTK) Latest News

pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 24, 2025

Shattuck Labs (STTK) to Release Earnings on Thursday - Defense World

Apr 24, 2025
pulisher
Apr 14, 2025

Shattuck Labs, Inc. (NASDAQ:STTK) Receives $7.50 Average Price Target from Analysts - Defense World

Apr 14, 2025
pulisher
Apr 09, 2025

Shattuck Labs at 24th Annual Needham Conference: Strategic IBD Focus By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 08, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 08, 2025
pulisher
Apr 08, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 08, 2025
pulisher
Apr 08, 2025

3 Promising Penny Stocks With Market Caps Under $300M - simplywall.st

Apr 08, 2025
pulisher
Apr 08, 2025

Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 08, 2025
pulisher
Apr 07, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

12 Health Care Stocks Moving In Monday's Intraday SessionAditxt (NASDAQ:ADTX), Alumis (NASDAQ:ALMS) - Benzinga

Apr 07, 2025
pulisher
Apr 03, 2025

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Apr 03, 2025
pulisher
Apr 02, 2025

24,446 Shares in Shattuck Labs, Inc. (NASDAQ:STTK) Acquired by Virtu Financial LLC - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Biotech Spotlight: Shattuck Labs CEO Set for Major Investor Presentation at Needham Conference - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

STTK stock plunges to 52-week low, touches $0.93 - Investing.com

Apr 01, 2025
pulisher
Mar 31, 2025

Brokers Issue Forecasts for Shattuck Labs Q1 Earnings - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

515,619 Shares in Shattuck Labs, Inc. (NASDAQ:STTK) Acquired by Takeda Pharmaceutical Co. Ltd. - MarketBeat

Mar 30, 2025
pulisher
Mar 28, 2025

H.C. Wainwright holds Shattuck Labs stock at Neutral - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Shattuck Labs Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

Shattuck Labs (NASDAQ:STTK) Given Neutral Rating at HC Wainwright - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Shattuck Labs’ (STTK) “Hold” Rating Reaffirmed at Needham & Company LLC - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Shattuck Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

Shattuck Labs Inc (STTK) Q4 2024 Earnings: EPS of -$0.37 Misses Estimate, Revenue of $0.71M Below Expectations - GuruFocus

Mar 27, 2025
pulisher
Mar 27, 2025

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

Shattuck Labs, Inc Loss At -$18.68 Mln In Q4 - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business - Bluefield Daily Telegraph

Mar 27, 2025
pulisher
Mar 26, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of STTK, TLS and ASTR - ACCESS Newswire

Mar 26, 2025
pulisher
Mar 21, 2025

Leerink Partnrs Forecasts Shattuck Labs FY2024 Earnings - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Brokerages Set Shattuck Labs, Inc. (NASDAQ:STTK) Target Price at $7.50 - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Shattuck Labs (NASDAQ:STTK) Upgraded at Leerink Partnrs - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Shattuck Labs (NASDAQ:STTK) Coverage Initiated by Analysts at Leerink Partners - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Leerink Partners Initiates Coverage of Shattuck Labs (STTK) with Outperform Recommendation - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Leerink initiates Shattuck Labs stock with Outperform, $4 target By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Leerink Partners Initiates Shattuck Labs at Outperform With $4 Price Target -March 17, 2025 at 07:39 am EDT - MarketScreener

Mar 17, 2025
pulisher
Mar 14, 2025

Stocks Recover Some of This Week’s Losses as US Shutdown Seems Averted - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

Stocks Rally as US Government Shutdown Risks Recede - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Tariff Worries Pressure Stocks - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Tariff Worries Sink Stocks - TradingView

Mar 13, 2025
pulisher
Mar 11, 2025

Favourable Signals For Shattuck Labs: Numerous Insiders Acquired Stock - Yahoo Finance

Mar 11, 2025
pulisher
Mar 02, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of STTK, RIVN and FB - ACCESS Newswire

Mar 02, 2025
pulisher
Feb 28, 2025

Shattuck Labs Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView

Feb 28, 2025
pulisher
Feb 25, 2025

CLVT, SLI & STTK: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Upcoming Class Actions Deadlines and Encourages Shareholders to Contact the Firm - ACCESS Newswire

Feb 25, 2025
pulisher
Feb 22, 2025

Shattuck Labs (STTK) Projected to Post Earnings on Wednesday - MarketBeat

Feb 22, 2025
pulisher
Feb 20, 2025

Shattuck Labs reports positive preclinical SL-325 data By Investing.com - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 20, 2025

Shattuck Labs reports positive preclinical SL-325 data - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at ... - The Bakersfield Californian

Feb 20, 2025
pulisher
Feb 20, 2025

Breakthrough in IBD Treatment? Shattuck's Novel DR3 Blocker Achieves Perfect Safety Score - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

Shattuck Labs (STTK) Expected to Announce Earnings on Wednesday - Defense World

Feb 19, 2025

Shattuck Labs Inc Stock (STTK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):